Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells
ChemMedChem · 2026
DOI: 10.1002/cmdc.70308 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Geovana Guedes Silvestre und 13 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program of Bioactives Natural and Synthetics Products, PgPNSB, Federal University of Paraíba, João Pessoa, Brazil. Hauptthemen laut MEDLINE: Melanoma, Antineoplastic Agents, Drug Resistance, Neoplasm, Anthraquinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation of Research Support of Paraíba - FAPESQ-PB.
Abstract (Originalsprache)
Melanoma is an aggressive skin cancer characterized by rapid progression and frequent chemoresistance, which limits the success of current therapies. Saquayamycin B1 (SQ‐B1), an angucycline isolated from Streptomyces sp. I072, was investigated for its antimelanoma activity with emphasis on redox disruption. The compound was purified using M9 fermentation followed by semipreparative liquid chromatography, and its structure was confirmed through 1D/2D nuclear magnetic resonance (NMR) and mass spectrometry. Cytotoxicity assays (MTT, 72 h) in SK‐MEL‐5, −113, −117, and −134 cells revealed IC 50 values between 5.01 and 0.99 μM. Pretreatment with N‐acetylcysteine (NAC) rescued cell viability at IC 50 and sub‐IC 50 concentrations, supporting a ROS‐dependent mechanism. SQ‐B1 (4 μM, 24 h) reduced the GSH/GSSG ratio (3.49 ± 0.70 vs. 12.35 ± 0.27 in controls) and increased O 2•− and NO • levels, indicating marked oxidative imbalance. Molecular docking suggested strong binding of SQ‐B1 to glutathione transferase (GSTP1‐1; p ≈ 0.86) and glutathione reductase (GSR; p ≈ 0.97), with weaker affinity for GPx4 ( p ≈ 0.35). Molecular dynamics confirmed stable interactions between SQ‐B1 and GSR (RMSD plateau ~10 ns) with a total interaction energy of −201.0 kJ/mol. These findings indicate that SQ‐B1 induces cytotoxicity through targeting of key redox regulators, highlighting its potential as a redox‐modulating candidate for chemoresistant melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program of Bioactives Natural and Synthetics Products, PgPNSB, Federal University of Paraíba, João Pessoa, Brazil.
- UR2160 ISOMER, Nantes University, Nantes, France.
- CHU Nantes, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes University, Nantes, France.
- FACISA, Federal University of Rio Grande do Norte, Santa Cruz, Brazil.
- CBIOTEC, Biotechnology Center, Federal University of Paraíba, João Pessoa, Brazil.
- UMR Inserm 1235 TENS, Nantes University, Nantes, France.
ORCID-Profile: Samuel Cibulski, Marcus Tullius Scotti, Angela Tesse, Marianna Vieira Sobral
Förderung
- Foundation of Research Support of Paraíba - FAPESQ-PB
Zitieren
APA
Silvestre, G. G., Souza, T. A., Alves, A. F., Dutan-Patiño, V., Huvelin, J. M., Gourdel, M., Croyal, M., Cibulski, S., Araújo, D. A. M., Scotti, M. T., Tavares, J. F., Tesse, A., Nazih, E. H., & Sobral, M. V. (2026). Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells. ChemMedChem. https://doi.org/10.1002/cmdc.70308
Vancouver
Silvestre GG, Souza TA, Alves AF, Dutan-Patiño V, Huvelin JM, Gourdel M, et al. Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells. ChemMedChem. 2026. doi:10.1002/cmdc.70308
BibTeX
@article{Silvestre2026,
author = {Silvestre, Geovana Guedes and Souza, Thalisson Amorim de and Alves, Alan Ferreira and Dutan-Patiño, Valeria and Huvelin, Jean-Michel and Gourdel, Mathilde and Croyal, Mikael and Cibulski, Samuel and Araújo, Demetrius Antonio Machado de and Scotti, Marcus Tullius and Tavares, Josean Fechine and Tesse, Angela and Nazih, El-Hassan and Sobral, Marianna Vieira},
title = {Redox Disruption Induced by Saquayamycin B1 Promotes Cytotoxicity in Resistant Melanoma Cells},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70308}
}
EUVIMED